It was a tough week for Indian shares as the BSE Sensex fell nearly 3 percent and the Nifty lost 3.3 percent as U.S. Fed chief Bernanke’s suggestion that stimulus measures may be scaled back at one of their next few meetings dented sentiment. Here's a look at the top Sensex losers and gainers. Full Article
For months, markets have been dancing to central bankers' tune, but that may now be changing, writes James Saft. Full Article
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Dishman close to deal with AstraZeneca, Merck-source
MUMBAI (Reuters) - Dishman Pharmaceuticals & Chemicals Ltd is close to signing contracts with U.S. Merck & Co Inc and AstraZeneca for supplying bulk drugs, a source close to the deal said on Tuesday.
"The contracts are expected to be signed in a month's time," the source, who declined to be named told Reuters.
Dishman already has a long-term contract manufacturing deal with Dutch Solvay for supplying bulk drugs and intermediates.
Global pharmaceutical giants are increasingly outsourcing drug manufacturing to companies in India as they seek to benefit from lower manufacturing costs here.
- Tweet this
- Share this
- Digg this